Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study

Evaluation of Anagrelide (Xagrid(®)) Efficacy and Long-term Safety, a phase IV, prospective, non-interventional study performed in 13 European countries enrolled high-risk essential thrombocythemia patients treated with cytoreductive therapy. The primary objectives were safety and pregnancy outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Birgegård, Gunnar, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire N., Hamdani, Mohamed, Wu, Jingyang, Achenbach, Heinrich, Kiladjian, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777190/
https://www.ncbi.nlm.nih.gov/pubmed/29079600
http://dx.doi.org/10.3324/haematol.2017.174672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777190/
https://www.ncbi.nlm.nih.gov/pubmed/29079600
http://dx.doi.org/10.3324/haematol.2017.174672

Ejemplares similares